Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinopathy caused by a variant in the X-linked gene, RPGR.
Biomarker and diagnostic research for RPGR-related retinopathy has been reported in the published literature.
No clinical trials have been registered for RPGR-related retinopathy.
91 publications have been identified in PubMed for RPGR-related retinopathy. Research spans Epidemiology / Natural History (36%), Basic Science / Preclinical (19%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 33 | 36% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:56 PM UTC
Common questions about RPGR-related retinopathy
Laboratory research
17 |
19% |
Research summaries | 14 | 15% |
Testing and diagnosis research | 9 | 10% |
Patient case studies | 7 | 8% |
Clinical study results | 5 | 5% |
New treatment approaches | 5 | 5% |
Other research | 1 | 1% |
Wu Y (2026). [PMID: 41915430](https://pubmed.ncbi.nlm.nih.gov/41915430/). *J Clin Invest*. [Basic Science / Preclinical]
Sassen SH (2026). [PMID: 41603938](https://pubmed.ncbi.nlm.nih.gov/41603938/). *Ophthalmologie*. [Basic Science / Preclinical]
Sourd C (2026). [PMID: 42137601](https://pubmed.ncbi.nlm.nih.gov/42137601/). *Mol Ther Adv*. [Gene Therapy / Novel Therapeutics]
Taha I (2026). [PMID: 42106701](https://pubmed.ncbi.nlm.nih.gov/42106701/). *BMC Ophthalmol*. [Review / Meta-Analysis]
Schofield D (2026). [PMID: 42168561](https://pubmed.ncbi.nlm.nih.gov/42168561/). *Eye (Lond)*. [Review / Meta-Analysis]
Zaydon Y (2026). [PMID: 42106178](https://pubmed.ncbi.nlm.nih.gov/42106178/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Long Y (2026). [PMID: 41480687](https://pubmed.ncbi.nlm.nih.gov/41480687/). *Int J Mol Med*. [Review / Meta-Analysis]
Lindquist M (2026). [PMID: 41492285](https://pubmed.ncbi.nlm.nih.gov/41492285/). *Ophthalmol Sci*. [Diagnostic / Biomarker]
Park JH (2026). [PMID: 41941273](https://pubmed.ncbi.nlm.nih.gov/41941273/). *J Cell Biol*. [Epidemiology / Natural History]
Yang J (2026). [PMID: 41773775](https://pubmed.ncbi.nlm.nih.gov/41773775/). *Transl Vis Sci Technol*. [Review / Meta-Analysis]